Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 329

1.

Reply to: Cardiovascular risk assessment in patients with ANCA-associated vasculitis.

Wallace ZS, Stone JH.

Arthritis Rheumatol. 2019 Aug 12. doi: 10.1002/art.41079. [Epub ahead of print]

PMID:
31403264
2.

Immunoglobulin G4-related Disease.

Wallace ZS, Perugino C, Matza M, Deshpande V, Sharma A, Stone JH.

Clin Chest Med. 2019 Sep;40(3):583-597. doi: 10.1016/j.ccm.2019.05.005. Review.

PMID:
31376893
3.

The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis.

Berti A, Warner R, Johnson K, Cornec D, Schroeder DR, Kabat BF, Langford CA, Kallenberg CGM, Seo P, Spiera RF, St Clair EW, Fervenza FC, Stone JH, Monach PA, Specks U, Merkel PA; RAVE-ITN Research Group.

J Autoimmun. 2019 Jul 15:102302. doi: 10.1016/j.jaut.2019.07.001. [Epub ahead of print]

PMID:
31320177
4.

B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease.

Della-Torre E, Rigamonti E, Perugino C, Baghai-Sain S, Sun N, Kaneko N, Maehara T, Rovati L, Ponzoni M, Milani R, Lanzillotta M, Mahajan V, Mattoo H, Molineris I, Deshpande V, Stone JH, Falconi M, Manfredi AA, Pillai S.

J Allergy Clin Immunol. 2019 Jul 15. pii: S0091-6749(19)30936-4. doi: 10.1016/j.jaci.2019.07.004. [Epub ahead of print]

PMID:
31319101
5.

The Association of Pulmonary Haemorrhage, Positive PR3-ANCA and Urinary Red Blood Cell Casts with Venous Thromboembolism in ANCA-Associated Vasculitis.

Kronbichler A, Leierer J, Shin JI, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CGM, St Clair EW, Brunetta P, Fervenza FC, Geetha D, Keogh KA, Monach PA, Ytterberg SR, Mayer G, Specks U, Stone JH; RAVE−ITN Research Group.

Arthritis Rheumatol. 2019 Jun 19. doi: 10.1002/art.41017. [Epub ahead of print]

PMID:
31216123
6.

Disease Activity, ANCA-Type, and Lipid Levels in ANCA-Associated Vasculitis.

Wallace ZS, Fu X, Liao K, Kallenberg CGM, Langford CA, Merkel PA, Monach P, Seo P, Specks U, Spiera R, St Clair EW, Zhang Y, Choi H, Stone JH.

Arthritis Rheumatol. 2019 Jun 4. doi: 10.1002/art.41006. [Epub ahead of print]

PMID:
31162829
7.

Phospholipase A2 receptor-associated membranous nephropathy in a patient with IgG4-related disease: A case report.

Muhsin SA, Masia R, Smith RN, Wallace ZS, Perugino CA, Stone JH, Niles JL, Cortazar FB.

Medicine (Baltimore). 2019 May;98(20):e15616. doi: 10.1097/MD.0000000000015616.

8.

IgG4-related disease: Association with a rare gene variant expressed in cytotoxic T cells.

Newman JH, Shaver A, Sheehan JH, Mallal S, Stone JH, Pillai S, Bastarache L, Riebau D, Allard-Chamard H, Stone WM, Perugino C, Pilkinton M, Smith SA, McDonnell WJ, Capra JA, Meiler J, Cogan J, Xing K, Mahajan VS, Mattoo H, Hamid R, Phillips JA 3rd; Undiagnosed Disease Network.

Mol Genet Genomic Med. 2019 Jun;7(6):e686. doi: 10.1002/mgg3.686. Epub 2019 Apr 16.

9.

Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab.

Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schulze-Koops H, Schett G, Spiera R, Unizony SH, Collinson N.

Arthritis Rheumatol. 2019 Aug;71(8):1329-1338. doi: 10.1002/art.40876. Epub 2019 Jul 3.

PMID:
30835950
10.

Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial.

Strand V, Dimonaco S, Tuckwell K, Klearman M, Collinson N, Stone JH.

Arthritis Res Ther. 2019 Feb 20;21(1):64. doi: 10.1186/s13075-019-1837-7.

11.

Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data.

Gale S, Trinh H, Tuckwell K, Collinson N, Stone JH, Sarsour K, Pei J, Best J, Birchwood C, Mohan SV.

Rheumatol Ther. 2019 Mar;6(1):77-88. doi: 10.1007/s40744-019-0139-5. Epub 2019 Feb 1.

12.

Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis.

Wallace ZS, Choi H, Stone JH.

Ann Rheum Dis. 2019 Jan 30. pii: annrheumdis-2019-215009. doi: 10.1136/annrheumdis-2019-215009. [Epub ahead of print] No abstract available.

PMID:
30700422
13.

Clinical features and mechanistic insights regarding IgG4-related dacryoadenitis and sialoadenitis: a review.

Maehara T, Pillai S, Stone JH, Nakamura S.

Int J Oral Maxillofac Surg. 2019 Jul;48(7):908-916. doi: 10.1016/j.ijom.2019.01.006. Epub 2019 Jan 25. Review.

PMID:
30686634
14.

Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts.

Wallace ZS, Zhang Y, Perugino CA, Naden R, Choi HK, Stone JH; ACR/EULAR IgG4-RD Classification Criteria Committee.

Ann Rheum Dis. 2019 Mar;78(3):406-412. doi: 10.1136/annrheumdis-2018-214603. Epub 2019 Jan 5.

PMID:
30612117
15.

Case 39-2018: An 18-Year-Old Man with Diplopia and Proptosis of the Left Eye.

Lefebvre DR, Reinshagen KL, Yoon MK, Stone JH, Stagner AM.

N Engl J Med. 2018 Dec 20;379(25):2452-2461. doi: 10.1056/NEJMcpc1807503. No abstract available.

PMID:
30575493
16.

Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis.

Wallwork R, Wallace Z, Perugino C, Sharma A, Stone JH.

Medicine (Baltimore). 2018 Oct;97(42):e12631. doi: 10.1097/MD.0000000000012631.

17.

Neuro-ophthalmic complications of IgG4-related disease.

Chwalisz BK, Stone JH.

Curr Opin Ophthalmol. 2018 Nov;29(6):485-494. doi: 10.1097/ICU.0000000000000523. Review.

PMID:
30199519
18.

The expansion in lymphoid organs of IL-4+ BATF+ T follicular helper cells is linked to IgG4 class switching in vivo.

Maehara T, Mattoo H, Mahajan VS, Murphy SJ, Yuen GJ, Ishiguro N, Ohta M, Moriyama M, Saeki T, Yamamoto H, Yamauchi M, Daccache J, Kiyoshima T, Nakamura S, Stone JH, Pillai S.

Life Sci Alliance. 2018 Jan;1(1). pii: e201800050. doi: 10.26508/lsa.201800050. Epub 2018 Apr 5.

19.

Foreword: clinical challenges of diagnosing and managing giant cell arteritis.

Stone JH.

Rheumatology (Oxford). 2018 Feb 1;57(suppl_2):ii1-ii2. doi: 10.1093/rheumatology/key003. No abstract available.

PMID:
29982783
20.

Why do temporal arteries go wrong? Principles and pearls from a clinician and a pathologist.

Banz Y, Stone JH.

Rheumatology (Oxford). 2018 Feb 1;57(suppl_2):ii3-ii10. doi: 10.1093/rheumatology/kex524.

PMID:
29982782
21.

Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis.

Sreih AG, Ezzedine R, Leng L, Fan J, Yao J, Reid D, Piecychna M, Carette S, Cuthbertson D, Dellaripa P, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Mahr A, McAlear CA, Maksimowicz-Mckinnon K, Monach PA, Seo P, Specks U, St Clair EW, Stone JH, Ytterberg SR, Edberg J, Merkel PA, Bucala R.

Arthritis Rheumatol. 2018 Dec;70(12):2077-2086. doi: 10.1002/art.40655. Epub 2018 Oct 22.

PMID:
29953750
22.

Identification of galectin-3 as an autoantigen in patients with IgG4-related disease.

Perugino CA, AlSalem SB, Mattoo H, Della-Torre E, Mahajan V, Ganesh G, Allard-Chamard H, Wallace Z, Montesi SB, Kreuzer J, Haas W, Stone JH, Pillai S.

J Allergy Clin Immunol. 2019 Feb;143(2):736-745.e6. doi: 10.1016/j.jaci.2018.05.011. Epub 2018 May 29.

PMID:
29852256
23.

Improved survival with renal transplantation for end-stage renal disease due to granulomatosis with polyangiitis: data from the United States Renal Data System.

Wallace ZS, Wallwork R, Zhang Y, Lu N, Cortazar F, Niles JL, Heher E, Stone JH, Choi HK.

Ann Rheum Dis. 2018 Sep;77(9):1333-1338. doi: 10.1136/annrheumdis-2018-213452. Epub 2018 May 14.

PMID:
29760156
24.

Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Berti A, Warner R, Johnson K, Cornec D, Schroeder D, Kabat B, Langford CA, Hoffman GS, Fervenza FC, Kallenberg CGM, Seo P, Spiera R, St Clair EW, Brunetta P, Stone JH, Merkel PA, Specks U, Monach PA; RAVE-ITN Research Group.

Arthritis Rheumatol. 2018 Jul;70(7):1114-1121. doi: 10.1002/art.40471. Epub 2018 May 7.

25.

Reducing glucocorticoid duration in ANCA-associated vasculitis: A pilot trial.

Miloslavsky EM, Niles JL, Wallace ZS, Cortazar FB, Fernandes A, Laliberte K, Stone JH.

Semin Arthritis Rheum. 2018 Oct;48(2):288-292. doi: 10.1016/j.semarthrit.2018.01.013. Epub 2018 Feb 3.

PMID:
29530330
26.

A CD8α- Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment.

Della-Torre E, Bozzalla-Cassione E, Sciorati C, Ruggiero E, Lanzillotta M, Bonfiglio S, Mattoo H, Perugino CA, Bozzolo E, Rovati L, Arcidiacono PG, Balzano G, Lazarevic D, Bonini C, Falconi M, Stone JH, Dagna L, Pillai S, Manfredi AA.

Arthritis Rheumatol. 2018 Jul;70(7):1133-1143. doi: 10.1002/art.40469. Epub 2018 May 20.

27.

An International Multispecialty Validation Study of the IgG4-Related Disease Responder Index.

Wallace ZS, Khosroshahi A, Carruthers MD, Perugino CA, Choi H, Campochiaro C, Culver EL, Cortazar F, Della-Torre E, Ebbo M, Fernandes A, Frulloni L, Hart PA, Karadag O, Kawa S, Kawano M, Kim MH, Lanzillotta M, Matsui S, Okazaki K, Ryu JH, Saeki T, Schleinitz N, Tanasa P, Umehara H, Webster G, Zhang W, Stone JH.

Arthritis Care Res (Hoboken). 2018 Nov;70(11):1671-1678. doi: 10.1002/acr.23543.

PMID:
29457382
28.

IgG4-related disease of the central and peripheral nervous systems.

AbdelRazek MA, Venna N, Stone JH.

Lancet Neurol. 2018 Feb;17(2):183-192. doi: 10.1016/S1474-4422(17)30471-4. Review.

PMID:
29413316
29.

The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis.

Rhee RL, Davis JC, Ding L, Fervenza FC, Hoffman GS, Kallenberg CGM, Langford CA, McCune WJ, Monach PA, Seo P, Spiera R, St Clair EW, Specks U, Stone JH, Merkel PA.

Clin J Am Soc Nephrol. 2018 Feb 7;13(2):251-257. doi: 10.2215/CJN.04160417. Epub 2018 Jan 25.

30.

Improving Mortality in End-Stage Renal Disease Due to Granulomatosis With Polyangiitis (Wegener's) From 1995 to 2014: Data From the United States Renal Data System.

Wallace ZS, Zhang Y, Lu N, Stone JH, Choi HK.

Arthritis Care Res (Hoboken). 2018 Oct;70(10):1495-1500. doi: 10.1002/acr.23521. Epub 2018 Sep 1.

PMID:
29361200
31.

Case 2-2018. A 41-Year-Old Woman with Vision Disturbances and Headache.

Cestari DM, Cunnane ME, Rizzo JF 3rd, Stone JH.

N Engl J Med. 2018 Jan 18;378(3):282-289. doi: 10.1056/NEJMcpc1701763. No abstract available.

PMID:
29342391
32.

Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.

Cornec D, Kabat BF, Mills JR, Cheu M, Hummel AM, Schroeder DR, Cascino MD, Brunetta P, Murray DL, Snyder MR, Fervenza F, Hoffman GS, Kallenberg CGM, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Stone JH, Barnidge DR, Specks U.

Rheumatology (Oxford). 2018 Apr 1;57(4):639-650. doi: 10.1093/rheumatology/kex484.

33.

Lymphomas in IgG4-related disease: clinicopathologic features in a Western population.

Bledsoe JR, Wallace ZS, Stone JH, Deshpande V, Ferry JA.

Virchows Arch. 2018 May;472(5):839-852. doi: 10.1007/s00428-017-2286-9. Epub 2017 Dec 28.

PMID:
29285637
34.

Reply.

Perugino CA, Stone JH.

Arthritis Rheumatol. 2018 Feb;70(2):318. doi: 10.1002/art.40362. Epub 2018 Jan 3. No abstract available.

35.

Neurologic Features of Immunoglobulin G4-Related Disease.

AbdelRazek M, Stone JH.

Rheum Dis Clin North Am. 2017 Nov;43(4):621-631. doi: 10.1016/j.rdc.2017.06.010. Review.

PMID:
29061247
36.

Trial of Tocilizumab in Giant-Cell Arteritis.

Stone JH, Klearman M, Collinson N.

N Engl J Med. 2017 Oct 12;377(15):1494-1495. doi: 10.1056/NEJMc1711031. No abstract available.

PMID:
29020600
37.

Immunoglobulin G4-related Aortitis: A Clinical Pathology Conference Held by the Division of Rheumatology at the Hospital for Special Surgery.

Unlu O, Schulman E, Wolff SD, Narula N, Stone JH, Bass A, Erkan D.

HSS J. 2017 Oct;13(3):307-312. doi: 10.1007/s11420-017-9565-5. Epub 2017 Jun 23. No abstract available.

38.

Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.

Geetha D, Sethi S, De Vriese AS, Specks U, Kallenberg CGM, Lim N, Spiera R, St Clair EW, Merkel PA, Seo P, Monach PA, Lepori N, Fessler BJ, Langford CA, Hoffman GS, Sharma R, Stone JH, Fervenza FC; RAVE-ITN Research Group.

Am J Nephrol. 2017;46(3):231-238. doi: 10.1159/000480443. Epub 2017 Sep 8.

39.

Atypical IgG4+ Plasmacytic Proliferations and Lymphomas: Characterization of 11 Cases.

Bledsoe JR, Wallace ZS, Deshpande V, Richter JR, Klapman J, Cowan A, Stone JH, Ferry JA.

Am J Clin Pathol. 2017 Sep 1;148(3):215-235. doi: 10.1093/AJCP/AQX067.

PMID:
28821195
40.

Case 14-2017: A Man with Pain and Swelling of the Left Calf and a Purpuric Rash.

Miloslavsky EM, Stone JH.

N Engl J Med. 2017 Aug 10;377(6):601. doi: 10.1056/NEJMc1707419. No abstract available.

PMID:
28792877
41.

Trial of Tocilizumab in Giant-Cell Arteritis.

Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schett G, Schulze-Koops H, Spiera R, Unizony SH, Collinson N.

N Engl J Med. 2017 Jul 27;377(4):317-328. doi: 10.1056/NEJMoa1613849.

42.

Reply.

Rovin BH, Birmingham D, Cartin-Ceba R, Specks U, Stone JH.

Arthritis Rheumatol. 2017 Nov;69(11):2247-2248. doi: 10.1002/art.40220. No abstract available.

43.

Emerging Treatment Models in Rheumatology: IgG4-Related Disease: Insights Into Human Immunology and Targeted Therapies.

Perugino CA, Mattoo H, Mahajan VS, Maehara T, Wallace ZS, Pillai S, Stone JH.

Arthritis Rheumatol. 2017 Sep;69(9):1722-1732. doi: 10.1002/art.40168. Epub 2017 Aug 8. Review. No abstract available.

44.

Case 14-2017 - A 20-Year-Old Man with Pain and Swelling of the Left Calf and a Purpuric Rash

Miloslavsky EM, Stone JH, Moy AP.

N Engl J Med. 2017 May 11;376(19):1868-1877. doi: 10.1056/NEJMcpc1616397. No abstract available.

PMID:
28489991
45.

Reply.

Rovin BH, Birmingham D, Cartin-Ceba R, Specks U, Stone JH.

Arthritis Rheumatol. 2017 Jul;69(7):1507-1508. doi: 10.1002/art.40121. Epub 2017 May 31. No abstract available.

46.

IgG4-related disease.

Bozzalla Cassione E, Stone JH.

Curr Opin Rheumatol. 2017 May;29(3):223-227. doi: 10.1097/BOR.0000000000000383. Review.

47.

Is MuSK myasthenia gravis linked to IgG4-related disease?

Raibagkar P, Ferry JA, Stone JH.

J Neuroimmunol. 2017 Apr 15;305:82-83. doi: 10.1016/j.jneuroim.2017.02.004. Epub 2017 Feb 7.

PMID:
28284351
48.

Case 6-2017. A 57-year-old woman with fatigue, sweats, weight loss, headache, and skin lesions.

Monach PA, Stone JH, Sharma A, Nazarian RM.

N Engl J Med. 2017 Feb 23;376(8):775-786. doi: 10.1056/NEJMcpc1613461. No abstract available.

PMID:
28225681
49.

Clonally expanded cytotoxic CD4+ T cells and the pathogenesis of IgG4-related disease.

Mattoo H, Stone JH, Pillai S.

Autoimmunity. 2017 Feb;50(1):19-24. doi: 10.1080/08916934.2017.1280029. Review.

50.

Roles of Plasmablasts and B Cells in IgG4-Related Disease: Implications for Therapy and Early Treatment Outcomes.

Lanzillotta M, Della-Torre E, Stone JH.

Curr Top Microbiol Immunol. 2017;401:85-92. doi: 10.1007/82_2016_58. Review.

PMID:
28091934

Supplemental Content

Loading ...
Support Center